Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306658486> ?p ?o ?g. }
- W4306658486 endingPage "1475" @default.
- W4306658486 startingPage "1475" @default.
- W4306658486 abstract "Guidelines have increasingly stressed the concept that adequate glycemic control is required to prevent or decrease the macro- and microvascular complications of type 2 diabetes mellitus (T2DM). PPAR-gamma agonists (glitazones) are no longer prioritized due to their effects on heart failure. However, the association between these drugs and innovative therapies could be a valuable tool to attenuate the risk factors of the metabolic syndrome. Glitazones are used for the treatment of diabetes and associated comorbidities. There is substantial scientific evidence demonstrating the effect of glitazones at a cardiometabolic level, as well as on hematological and neurological pathologies that point to their usefulness. The use of glitazones has always been controversial both for the type of patients who must take these drugs and for the side effects associated with them. Unfortunately, the recent guidelines do not include them among the preferred drugs for the treatment of hyperglycemia and rosiglitazone is out of the market in many countries due to an adverse cardiovascular risk profile. Even though real-life studies have proven otherwise, and their pleiotropic effects have been highlighted, they have been unable to achieve primacy in the choice of antihyperglycemic drugs. It would be appropriate to demonstrate the usefulness of pioglitazone and its therapeutic benefit with further cardiovascular safety studies." @default.
- W4306658486 created "2022-10-18" @default.
- W4306658486 creator A5002770606 @default.
- W4306658486 creator A5008776901 @default.
- W4306658486 creator A5020990786 @default.
- W4306658486 creator A5041295864 @default.
- W4306658486 creator A5049777035 @default.
- W4306658486 creator A5049796469 @default.
- W4306658486 creator A5054572477 @default.
- W4306658486 creator A5064490540 @default.
- W4306658486 creator A5070545935 @default.
- W4306658486 creator A5071597695 @default.
- W4306658486 date "2022-10-17" @default.
- W4306658486 modified "2023-10-10" @default.
- W4306658486 title "An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes" @default.
- W4306658486 cites W1577136074 @default.
- W4306658486 cites W1826389973 @default.
- W4306658486 cites W1830151520 @default.
- W4306658486 cites W1868475579 @default.
- W4306658486 cites W1966566822 @default.
- W4306658486 cites W1966730025 @default.
- W4306658486 cites W1971082641 @default.
- W4306658486 cites W1973436528 @default.
- W4306658486 cites W1976060830 @default.
- W4306658486 cites W1990055069 @default.
- W4306658486 cites W1997416444 @default.
- W4306658486 cites W2001583779 @default.
- W4306658486 cites W2009058175 @default.
- W4306658486 cites W2009330135 @default.
- W4306658486 cites W2010699829 @default.
- W4306658486 cites W2014941838 @default.
- W4306658486 cites W2018739231 @default.
- W4306658486 cites W2024985023 @default.
- W4306658486 cites W2025643440 @default.
- W4306658486 cites W2036467420 @default.
- W4306658486 cites W2038449585 @default.
- W4306658486 cites W2038967042 @default.
- W4306658486 cites W2050158436 @default.
- W4306658486 cites W2056872469 @default.
- W4306658486 cites W2056973638 @default.
- W4306658486 cites W2058184727 @default.
- W4306658486 cites W2061524651 @default.
- W4306658486 cites W2061754398 @default.
- W4306658486 cites W2062812115 @default.
- W4306658486 cites W2064270413 @default.
- W4306658486 cites W2064617441 @default.
- W4306658486 cites W2071675848 @default.
- W4306658486 cites W2072664557 @default.
- W4306658486 cites W2075183867 @default.
- W4306658486 cites W2079454650 @default.
- W4306658486 cites W2081276121 @default.
- W4306658486 cites W2094201928 @default.
- W4306658486 cites W2096541753 @default.
- W4306658486 cites W2098451235 @default.
- W4306658486 cites W2098957321 @default.
- W4306658486 cites W2099673402 @default.
- W4306658486 cites W2100079513 @default.
- W4306658486 cites W2100548723 @default.
- W4306658486 cites W2102675827 @default.
- W4306658486 cites W2105342032 @default.
- W4306658486 cites W2109728760 @default.
- W4306658486 cites W2115360698 @default.
- W4306658486 cites W2116048591 @default.
- W4306658486 cites W2122113546 @default.
- W4306658486 cites W2122329183 @default.
- W4306658486 cites W2127125241 @default.
- W4306658486 cites W2131490500 @default.
- W4306658486 cites W2146264128 @default.
- W4306658486 cites W2146712490 @default.
- W4306658486 cites W2148521985 @default.
- W4306658486 cites W2150959326 @default.
- W4306658486 cites W2155342887 @default.
- W4306658486 cites W2158712961 @default.
- W4306658486 cites W2159969745 @default.
- W4306658486 cites W2165199383 @default.
- W4306658486 cites W2170353692 @default.
- W4306658486 cites W2172156812 @default.
- W4306658486 cites W2188021679 @default.
- W4306658486 cites W2274836352 @default.
- W4306658486 cites W2294456253 @default.
- W4306658486 cites W2334227342 @default.
- W4306658486 cites W2425644022 @default.
- W4306658486 cites W2470709274 @default.
- W4306658486 cites W2519510391 @default.
- W4306658486 cites W2536270858 @default.
- W4306658486 cites W2730268258 @default.
- W4306658486 cites W2751112502 @default.
- W4306658486 cites W2752583015 @default.
- W4306658486 cites W2755083612 @default.
- W4306658486 cites W2795605948 @default.
- W4306658486 cites W2800705815 @default.
- W4306658486 cites W2802787768 @default.
- W4306658486 cites W2804938814 @default.
- W4306658486 cites W2888321467 @default.
- W4306658486 cites W2900413769 @default.
- W4306658486 cites W2914053210 @default.
- W4306658486 cites W2919994166 @default.
- W4306658486 cites W2921816737 @default.